You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
聖濟堂(600227.SH):上半年預虧9300萬元-9700萬元
格隆匯 07-13 15:42

格隆匯7月13日丨聖濟堂(600227.SH)披露2022年半年度業績預虧公吿,預計2022年半年度實現歸屬於母公司所有者的淨利潤為-9300.00萬元到-9700.00萬元;預計2022年半年度實現歸屬於母公司所有者的扣除非經常性損益後的淨利潤為-9800.00萬元到-1.02億元。業績預虧的主要原因系:

(一)主營業務影響

1、該次業績下降的主要原因是公司根據《企業會計準則》的規定,對應收款項進行全面檢查並計提壞賬準備,預計減少淨利潤4700.00萬元。

2、公司全資子公司貴州赤天化桐梓化工有限公司於2021年12月10日至2022年1月23日期間對尿素、甲醇生產裝置進行停產檢修,大修費用增加,淨利潤減少2369.02萬元。

3、公司全資子公司貴州聖濟堂製藥有限公司持續受醫保控費、國家集採常態化等一系列醫藥政策影響,以及在業績預吿期間,聖濟堂製藥格列美脲片被暫停生產和銷售,並被聯合採購辦公室取消中選資格,導致公司醫藥板塊經營虧損。

(二)非經營性損益的影響

該次業績預吿期間,公司確認閒置“氣頭”尿素生產裝置處置收益尾款500.00萬元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account